Cancer Screening by Age in India: What's Recommended When
India's cancer screening guidelines lag Western ones and vary by professional body. The result: many families receive uncoordinated recommendations. A clear age-based framework helps decide what to do when, without over-screening or under-screening.
The specific cancers with evidence-based screening
- Cancer: Cervical (women) · Standard start age (India): 25-30 · Frequency: Every 3-5 years · Test: Pap smear or HPV test
- Cancer: Breast (women) · Standard start age (India): 40-45 avg risk · Frequency: Annually 40-55, then every 2 years · Test: Mammography
- Cancer: Colorectal · Standard start age (India): 50 (both sexes) · Frequency: Every 10 years if normal · Test: Colonoscopy
- Cancer: Oral · Standard start age (India): 40 (higher risk with tobacco) · Frequency: Annually · Test: Clinical exam
- Cancer: Prostate (men) · Standard start age (India): 50, individualised discussion · Frequency: Every 2-3 years · Test: PSA + clinical
- Cancer: Lung · Standard start age (India): 50-80 heavy smokers · Frequency: Annually · Test: Low-dose CT
- Cancer: Skin · Standard start age (India): Any age · Frequency: Annually if risk factors · Test: Full-body check
Earlier start ages if higher risk
- Family history — start 10 years before youngest affected relative.
- Known genetic syndromes (BRCA, Lynch) — much earlier, more frequent.
- Personal history of specific conditions (IBD, chronic viral hepatitis).
- Occupational exposures (asbestos, radiation, chemicals).
- Immunocompromise.
The Indian-specific considerations
- Oral cancer high due to tobacco/betel — annual dental screening includes this.
- Cervical cancer high in India — screening priority especially for lower-access populations.
- Breast cancer earlier onset than Western populations — 40 start age worth considering.
- Colorectal cancer rising in Indian urban populations.
- Gastric cancer higher in some regions (Kashmir, north-east) — endoscopy consideration.
The specific tests worth understanding
- Cervical: HPV test is more sensitive than Pap; either acceptable.
- Breast: mammography + clinical exam; ultrasound for dense breasts; MRI for high-risk.
- Colon: colonoscopy is gold standard; FIT test (fecal occult blood) is easier alternative.
- Prostate: PSA is imperfect but adds information to clinical exam.
- Lung: low-dose CT for eligible smokers; not for non-smokers.
What NOT to screen for routinely
- Ovarian cancer — no evidence-based screening for average risk.
- Pancreatic — no screening for average risk (BRCA/family history changes this).
- Testicular — self-exam, not routine imaging.
- Whole body MRI — no evidence of benefit for average risk; identifies benign findings that lead to biopsies.
- Random tumour marker checks (CA-125, CEA, AFP) — high false-positive rate.
The specific problem of over-screening
Screening is not neutral. Every screen has false positives, biopsies for benign findings, anxiety, cost, and occasional harm. Screening tests that reduce mortality by 10-20% for a specific cancer are worth it. Screening tests that don't reduce mortality but detect more disease can produce net harm (overdiagnosis, overtreatment).
The record to build
- Every screening test with date and result.
- Any biopsy result if follow-up needed.
- Family history of cancer with specific relative, cancer type, age at diagnosis.
- Next screening due date for each.
- Any risk-adjustment discussion with your doctor.
A person with 10 years of documented screening negative for the age-appropriate cancers has objective evidence of low risk in those areas. Without records, every new doctor starts the conversation fresh, sometimes reordering tests recently done.
References
Free for 90 days, no card needed. After that, keeping the record costs ₹349 for the year.
General information, not medical advice. Always talk to a qualified doctor about your own care. Where this and your doctor disagree, your doctor is right.